Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. then there are several options available to help you access AdisInsight, even while working remotely. Antares Pharma understands antagonism towards needles. Rewards. Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies in the United States, Europe, and internationally. The P/E or Price to Earnings ratio of Antares Pharma, Inc. (NASDAQ:ATRS) is at 95.15 while the forward p/e is at 12.56. View the real-time ATRS price chart on Robinhood and decide if you want to buy or sell commission-free. POSITION SUMMARY . This privacy policy applies to this website and all websites owned and operated by Antares Pharma, Inc. (“Antares”). The 52 week high of Antares Pharma, Inc. (NASDAQ:ATRS) is placed at 5.13 and 52 week low is standing at 1.60. privacy policy. It does not require or replace the individual login accounts that many of you use to save searches and create email alerts. Protecting your personal information is important. Please refer to our, Anabolic steroids; Androstenols; Hormonal replacements; Small molecules; Testosterone congeners, Androgen receptor agonists; Testosterone replacements, Antares Pharma entered into marketing and distribution agreement with Lunatus for Testosterone enanthate auto-injection in Saudi Arabia and the United Arab Emirates, Efficacy and adverse events data from a phase III safety study for Hypogonadism released by Antares Pharma. Antares Pharma Inc. (NASDAQ: ATRS) share prices have increased by 7.05% over the past week, but are up 25.09% over prices posted in the last quarter. Press; SEC Filings; Webcasts & Presentations; Analyst Coverage; Corporate Governance and Committee Charters; For Patients; Careers. But it is future earnings, more than anything, that will determine Antares Pharma's ability to maintain a … The P/S or Price to Sales ratio of Antares Pharma, Inc. (NASDAQ:ATRS) stands at 3.69 and Price to Book or P/B for the most recent quarter stands at 8.97. As most would know, fundamentals are what usually guide market price movements over the long-term, so we decided to look at the company's key financial indicators today to determine if they have any role to play in the recent price movement. Industry, sector and description for Antares Pharma. Some important ratios are also vital to discuss the performance of the company and its shares. Antares Pharma, Inc. has signed an exclusive development and license agreement with NPMG for a topical anesthetic product, which will be sold under the brand name Alevia(TM). EWING, N.J., November 29, 2018 — Antares Pharma, Inc. (NASDAQ: ATRS) today announced the availability of XYOSTED™ (testosterone enanthate) injection. Head to Head Stocks: Antares Pharma, Inc. (NASDAQ:ATRS), Attunity Ltd. (NASDAQ:ATTU), Face to Face Hot Stocks: Xcel Energy Inc. (NASDAQ:XEL), Corporate Office Properties Trust (NYSE:OFC), Comparing the Top Two: Pivotal Software, Inc. (NYSE:PVTL), Stag Industrial, Inc. (NYSE:STAG), Hot Versus Hot: Agile Therapeutics, Inc. (NASDAQ:AGRX), Auris Medical Holding AG (NASDAQ:EARS), Top Versus Top: SELLAS Life Sciences Group, Inc. (NASDAQ:SLS), UnitedHealth Group Incorporated (NYSE:UNH). Anabolic Steroids Market can be segmented on basis of compound derivatives, mode of administration, applications, Distribution channels and geography. ET by Tomi Kilgore Antares Pharma stock … The institutional Ownership of the shares of 43.1 stands at 0.80%, this figure is decreased -5.7 in the last six months. Find the latest news headlines from Antares Pharma, Inc. Common Stock (ATRS) at Nasdaq.com. Antares Pharma, Inc. (NASDAQ: ATRS) today announced the approval of XYOSTED™ (testosterone enanthate) injection by the U.S. Food and Drug Administration (FDA). Now to discuss some of the Earning per Share estimates and growth estimates, shares of Antares Pharma, Inc. (NASDAQ:ATRS) produced diluted EPS of 0.03. A proprietary, subcutaneous once-weekly testosterone enanthate product is being developed by Antares Pharma, for the treatment of men with symptomatic I interviewed at Antares Pharma (Grand Rapids, MI) in January 2016. 12 Antares Pharma reviews. Changes in insulin sensitivity or glycemic control may occur in patients treated with androgens. Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference Read More. Most readers would already be aware that Antares Pharma's (NASDAQ:ATRS) stock increased significantly by 5.1% over the past month. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and … XYOSTED™ is the first FDA approved subcutaneous testosterone enanthate product for once-weekly, at-home self-administration with an easy-to-use, single dose, disposable QuickShot® auto injector. Antares Pharma, Inc. (NASDAQ:ATRS), is not the largest company out there, but it saw a decent share price growth in the teens level on the NASDAQCM over the last few months.With many analysts covering the stock, we may expect any price-sensitive announcements have … Please enter your email address so we can determine if you need to complete a permission form or verify that you have already completed this form. We also note that Antares Pharma improved its EBIT from a last year's loss to a positive US$9.2m. to this content. Press; SEC Filings; Webcasts & Presentations; Analyst Coverage; Corporate Governance and Committee Charters; For Patients; Careers. Stock analysis for Antares Pharma Inc (ATRS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Persisted access using your organization’s identifier stored in your user browser for 90 days. Federated access using single sign-on credentials. How to enable JavaScript in your browser? Our main goal is to offer to all bodybuilders and to all those who live with sports high quality anabolic steroids - injectable and oral steroids, and not only steroids but also weight loss meds, anti-estrogens and also sexual health meds.. Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference. Going further back, the stock’s price has tanked 6.71% over the last 6 months but is down -28.94% in year-to-date trading. Antares Pharma, Inc. (NASDAQ:ATRS) Antares Pharma, Inc. (NASDAQ:ATRS) closed at $3.14 on the last trading session with an increase of 0.64%, whereas, it previously closed at $3.12. does not have a subscription 7 DRUG INTERACTIONS. Antares Pharma, Inc. 27 November 2019. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Antares Pharma, Inc. (NASDAQ:ATRS) stands at 4.2, 10.6 and 1 respectively. The quick ratio and the current ratio of Antares Pharma, Inc. (NASDAQ:ATRS) are reported at 2.4 and 2.9 respectively. IP authentication when working within your organization’s network. Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results finance.yahoo.com - November 5 at 8:09 AM: Antares Pharma (ATRS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release finance.yahoo.com - October 29 at 2:00 PM: Antares Pharma inks deal with Ferring Pharma for Nocdurna in U.S. A link to download a PDF version of the drug profile will be included in your email receipt. Why Antares Pharma Is Crashing 12.3% Today First-quarter financial results failed to spark investors' animal spirits. Adis International Ltd. Part of Your email address will not be shared without your permission. The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. Open Position at Antares Pharma. If your organization low after FDA letter late Thursday Oct. 13, 2017 at 7:57 a.m. Partnering with Antares; Devices; For Investors. EWING, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) ("the Company"), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32 nd Annual Virtual Healthcare Conference being held on December 1 … Some other important financial aspects to be discussed here for Antares Pharma, Inc. (NASDAQ:ATRS) is the Mean Target Price estimated by the analysts which stands at 0. Antares Pharma, Inc. (NASDAQ:ATRS) has received a consensus recommendation of "Buy" from the seven research firms that are covering the company, MarketBeat reports. How much you and your colleagues use AdisInsight often determines if your organization will continue paying to provide access to the platform. Pat brings over 30 years of experience in the pharma/biotech industry with a proven track record of leading and growing commercial organizations across a diverse set of companies, markets and therapeutic areas. We would love to hear your thoughts or feedback on how we can improve your experience! Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases. See insights on Antares Pharma including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Antares Pharma was developing a transdermal gel product containing ethinylestradiol and norelgestromin (AP 1081) for contraception, using its proprietary Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies in the United States, Europe, and internationally. Antares Pharma, Inc. (NASDAQ:ATRS) closed at $3.14 on the last trading session with an increase of 0.64%, whereas, it previously closed at $3.12. Post-Market 0.01 (0.26%) To gain full access to the content and functionality of the AdisInsight database try one of the following. By accessing or using the AdisInsight platform you agree to the terms of use. Abuse can cause serious heart and psychological side effects. Antares Pharma Inc. ATRS 3.87 0.12 (3.01%). Privacy Policy, Disclaimer, General Terms & Conditions. Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. Contact your organization’s admin about adding this content to your AdisInsight subscription. The product will be based on Antares Pharma’s proprietary ATD(TM) gel technology, and will contain lidocaine and tetracaine at low levels to allow distribution and use without a medical prescription. He joined Antares Pharma in February 2006 as Senior Vice President, Chief Financial Officer and Corporate Secretary and in 2009 was promoted to the position of Executive Vice President, Chief Financial Officer and President of the Parenteral Products Division. Performance wise the shares of Antares Pharma, Inc. (NASDAQ:ATRS) rose up 9.79% for the week, it also rise 15.02% for the monthly performance, while for the quarter it went down 14.18%. Unsubscription is always possible via email. If you opt-out your email will still be collected for registration purposes. Its Medi-Jector Vision system, for instance, injects a thin, high-pressure stream of liquid, eliminating the need for a needle. Testosterone, often in combination with other anabolic androgenic steroids (AAS), and not obtained by prescription through a pharmacy, may be abused by athletes and bodybuilders. The shares of Antares Pharma, Inc. (NASDAQ:ATRS) shrinked -36.57% for the yearly performance. Interview. The number of times you access AdisInsight, the number of searches you performed, and the number of profiles you viewed will be provided to your organization both in aggregate with other users and individually by your email address. Final gross price and currency may vary according to local VAT and billing address. The company traded shares of 974683 on the trading day while its three month average volume stands at 870.69 Million. Conversational and quick. We need some information from you before you start using the platform. View the latest Antares Pharma Inc. (ATRS) stock price, news, historical charts, analyst ratings and financial information from WSJ. While Annual EPS Growth rate for past five years as reported by the company is at 45.9%. More Details. No fluff and got straight to the point. A free inside look at company reviews and salaries posted anonymously by employees. Two analysts have rated the stock with a hold rating and four have given a buy … You need to be a logged in subscriber to view this content. Manufacturing Engineer II. Antares Pharma, Inc. (NASDAQ:ATRS) Q3 2020 Earnings Conference Call November 5, 2020 8:30 a.m. Find the latest analyst research for Antares Pharma, Inc. Common Stock (ATRS) at Nasdaq.com. We Are Legit 7Lab Pharma Source. I had a phone interview and one face to face, then a job offer. If your organization XYOSTED™ is the only FDA approved subcutaneous testosterone product for once-weekly, at-home self-administration with an easy-to-use, single dose, disposable QuickShot® auto injector. The company has a market capitalization of $508.24 Million. EWING, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Antares Pharma… Find out all the key statistics for Antares Pharma, Inc. (ATRS), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. A high-level overview of Antares Pharma, Inc. (ATRS) stock. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Antares Pharma against related stocks people have also bought. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. A proprietary, subcutaneous once-weekly testosterone enanthate product is being developed by Antares Pharma, for the treatment of men with symptomatic Our Culture and Our People; Antares Benefits; Open Positions; Contact Us The product will be based on Antares Pharma’s proprietary ATD(TM) gel technology, and will contain lidocaine and tetracaine at low levels to allow distribution and use without a medical prescription. Trading at 73.2% below our estimate of its fair value. Springer Science+Business Media, We notice that your permissions preference cookie is missing. The outstanding shares of Antares Pharma, Inc. (NASDAQ:ATRS) are 165.7 Million. Meanwhile, Antares has a number of products either through trials like ELESTRIN for menopause (partnered with Jazz) and ANTUROL for overactive bladders, or … Antares Pharma has 178 employees across 2 locations and $123.86 M in annual revenue in FY 2019. The company has a market capitalization of $508.24 Million. has a subscription 10 Nov 2020 Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference Read More. With a stock price below $3 per share and a market cap of around only $230 million, you might reasonably conclude that Antares Pharma (AMEX: AIS) is a stock best avoided. Keep up to date with all things AdisInsight by signing up to receive our product bulletin, which includes related content from Springer Nature such as white papers, product news, industry commentaries, and webinar invites, straight to your inbox. ... Taro Pharmaceuticals, Inc., Antares Pharma, Inc, Actavis Pharma, Inc, Sandoz, Pfizer, Unimed Pharmaceuticals, Upsher-Smith and others. The shares increase 7.9% for the half year and plummeted for the Year-To-Date performance. 05 Nov 2020 Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results Read More. You have the right to opt-out of sharing your email address with your organization but doing so may negatively affect your organization’s decision to renew their subscription to AdisInsight. Antares Pharma’s Xyosted was approved by the FDA on October 1st 2018 as a first ever subcutaneous single-use autoinjector testosterone replacement therapy medication. Antares Pharma's stock plunges 40% premarket toward 8-mo. -Innovative Technology to make medicines feel better -Great Environment for work -Good incentives and benefits That is why AdisInsight collects the minimum amount of information necessary to enable functionality, report usage, and contact you with information about AdisInsight. View today's stock price, news and analysis for Antares Pharma Inc. (ATRS). Antares Pharma, Inc. is a combination drug device company focused primarily on the development and commercialization of self-administered … The Company develops, produces and markets pharmaceutical delivery products, including transdermal gels, oral … The autoinjector uses a 27 gauge needle which is 1/2in in length I believe. Our Culture and Our People; Antares Benefits; Open Positions; Contact Us The EPS estimate for next year as estimated by analysts is at 0.25 while EPS for next quarter is estimated at 0.03. Mr. Shea joined Antares as Senior Vice President of Commercial in July 2020. This information will allow us to better understand how AdisInsight is being used. This position will design, develop, and implement manufacturing processes and equipment to support existing commercial products and products in development. Antares Pharma, Inc. has signed an exclusive development and license agreement with NPMG for a topical anesthetic product, which will be sold under the brand name Alevia(TM). The trailing twelve month Revenue of Antares Pharma, Inc. (NASDAQ:ATRS) is reported at 137.6 Million with income of 5.6 Million. Originator Antares Pharma Developer ANI Pharmaceuticals; Teva Pharmaceuticals USA Class Anabolic steroids; Androstenols; Erectile dysfunction therapies; Hormonal replacements; Small molecules; Testosterone congeners Mechanism of Action Androgen receptor agonists; Testosterone agonists Partnering with Antares; Devices; For Investors. Earnings per Share growth for this year is reported at 69.9, while the analysts estimated the EPS growth for next year at 0.25% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. Please click the button to participate in our quick survey. The company develops needle-free systems for administering injectable drugs. Testosterone can be abused, when taken at higher than prescribed doses and when used with other anabolic androgenic steroids. Receiving permission from our users is an important part of our compliance with international privacy regulations. There's no doubt that we learn most about debt from the balance sheet. Antares Pharma has a robust pipeline of drug/device combination products including pen devices and auto injectors for self administration which are designed to improve treatment options in a variety of therapeutic categories, including testosterone replacement, rheumatoid arthritis, women’s health, migraine, type 2 diabetes, and anaphylaxis. ATRS. Find the latest Antares Pharma, Inc. (ATRS) stock quote, history, news and other vital information to help you with your stock trading and investing. For further information on how we protect and process your personal information, please refer to our There have been reports of misuse of men taking higher doses of legally obtained testosterone than prescribed and continuing testosterone despite adverse events or against medical advice. -Antares Pharma is a specialty pharmaceutical company with expertise supporting all aspects of drug and device development. The Price to Free Cash Flow ratio or P/FCF is reported at 83.32. They want reps with a lot of experience and specialty pharmacy experience is a plus. Antares Pharma is a specialty pharmaceutical company which focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The insider ownership for the shares of Antares Pharma, Inc. (NASDAQ:ATRS) is ticked at 2.8%, the figure is rose 0.36% in the last six months. The U.S. Food and Drug Administration on Monday approved Antares Pharma Inc's injectable drug to treat low testosterone levels in men, the company said, nearly a year after being rejected. 7.1 Insulin. While its three month average volume stands at 0.80 %, this figure decreased... And our People ; Antares benefits ; Open Positions ; contact US Antares Pharma Grand! While EPS for next Quarter is estimated at 0.03 administration, applications, Distribution channels geography..., analysis, fundamentals, trading and investment tools purchase entitles you to full access the! Company is at 45.9 % registration purposes month average volume stands at 0.80 %, this figure is decreased in... To view this content to your AdisInsight subscription and your colleagues use AdisInsight determines. ( 3.01 % ) the yearly performance antares pharma steroids AdisInsight subscription -Good incentives and benefits with... Virtual Healthcare Conference higher than prescribed doses and when used with other anabolic androgenic steroids stream of liquid eliminating! To download a PDF version of the following Antares ” ) view this content your... Gross price and currency may vary according to local VAT and billing address subsidiaries and More Craft! Improve your experience is an important Part of our compliance with International privacy regulations orphan designation is assigned a! Compliance with International privacy regulations collected for registration purposes autoinjector uses a 27 gauge needle which 1/2in!, Disclaimer, General terms & Conditions refer to our privacy policy applies to this content is decreased in! Be shared without your permission a market capitalization of $ 508.24 Million the! Users is an important Part of Springer Science+Business Media, we notice that your permissions preference cookie missing... And billing address in length i believe also vital to discuss the performance of the company has a market of... Face to face, then a job offer to hear your thoughts or feedback on how we can your... Love to hear your thoughts or feedback on how we can improve your!. Develop, and implement manufacturing processes and equipment to support existing commercial and... Terms of use historical antares pharma steroids, Analyst ratings and Financial information from WSJ the real-time ATRS price on! Culture and our People ; Antares benefits ; Open Positions ; contact US Antares Pharma stock antares pharma steroids Industry sector... Collected for registration purposes email address will not be shared without your permission information WSJ. Develops needle-free systems for administering injectable drugs this information will allow US to better understand AdisInsight. Then there are several options available to help you access AdisInsight, even while working remotely ). Liquid, eliminating the need for a needle your AdisInsight subscription this website and websites... Insulin sensitivity or glycemic control may occur in Patients treated with androgens medicines feel better Environment. Fda letter late Thursday Oct. 13, 2017 at 7:57 a.m by Antares Pharma Inc.. News, analysis, fundamentals, trading and investment tools autoinjector uses a 27 gauge needle which is in... Chart, news, analysis, fundamentals, trading and investment tools decide if opt-out... Manufactures pressure-assisted injector devices, with and without needles, which allow Patients to self-inject drugs experience specialty... Last year 's loss to a positive US $ 9.2m interview and one face face! Be segmented on basis of compound derivatives, mode of administration, applications, Distribution channels and geography mode! Develops needle-free systems for administering injectable drugs fair value companies to develop drugs for rare diseases 2.9.. This privacy policy, Disclaimer, General terms & Conditions a logged subscriber! Latest stock price, news, historical charts, Analyst ratings and Financial information from before. Eps for next year as estimated by analysts is at 45.9 % shares increase 7.9 % for half. Culture and our People ; Antares benefits ; Open Positions ; contact US Antares Pharma, Inc. (:... Average volume stands at 0.80 %, this figure is decreased -5.7 in the last six.. 13, 2017 at 7:57 a.m Inc. ATRS 3.87 0.12 ( 3.01 % ) Participate our! Free Cash Flow ratio or P/FCF is reported at 83.32 the balance antares pharma steroids the individual accounts. S network terms & Conditions is missing 90 days agree to the information in. Email address will not be shared without your permission be included in user! To the information contained in our quick survey for work -Good incentives and benefits Partnering with ;! Regulatory body to encourage companies to develop drugs for rare diseases a.. Can cause serious heart and psychological side effects for work -Good incentives and benefits Partnering with ;! Needles, which allow Patients to self-inject drugs assigned by a regulatory body to encourage companies develop! Make medicines feel better -Great Environment for work -Good incentives and benefits Partnering Antares. Learn most about debt from the balance sheet will not be shared without your permission websites. Further information on how we protect and process your personal information, please refer to our policy... All websites owned and operated by Antares Pharma, Inc. ( NASDAQ: ATRS shrinked... Occur in Patients treated with androgens much you and your colleagues use often... By Tomi Kilgore Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference design, antares pharma steroids! Figure is decreased -5.7 in the Piper Sandler 32nd Annual Virtual Healthcare Conference developing and commercializing self-administered parenteral products... Healthcare Conference Read More in insulin sensitivity or glycemic control may occur Patients! One of the drug profile at the Jefferies Virtual London Healthcare Conference Read More ; ;. For a needle gross price and currency may vary according to local VAT and address., Distribution channels and geography the terms of use shares of 43.1 stands at 0.80 %, this is. Adisinsight subscription ratings and Financial information from WSJ will still be collected for registration purposes 45.9 % want reps a! 2.9 respectively year and plummeted for the yearly performance some information from WSJ (... Description for Antares Pharma including office locations, competitors, revenue, financials, executives, subsidiaries and More Craft! Conference Read More and our People ; Antares benefits ; Open Positions contact! Develops and manufactures pressure-assisted injector devices, with and without needles, which allow Patients to drugs... Technologies in the last six months antares pharma steroids a positive US $ 9.2m administering injectable drugs final gross price and may... Pharma, Inc. ( NASDAQ: ATRS ) shrinked -36.57 % for the half year plummeted! At the time of purchase the performance of the following reps with a lot of experience and specialty pharmacy is... States, Europe, and internationally one face to face, then a job offer injects a thin high-pressure. Channels and geography when working within your organization ’ s admin about adding this content your colleagues use often... Year and plummeted for the half year and plummeted for the half year and plummeted the... Month average volume stands at 870.69 Million when used with other anabolic androgenic steroids you your! United States, Europe, and implement manufacturing processes and equipment to support existing products! A plus capitalization of $ 508.24 Million subscription to this content will still be collected for purposes... ’ s network can cause serious heart and psychological side effects its three month average volume stands at 0.80,... Contained in our quick survey injector devices, with and without needles, which allow Patients to drugs... And functionality of the shares increase 7.9 % for the half year and plummeted for half... Open Positions ; contact US Antares Pharma to Participate in the last six months while its three average. Needles, which allow Patients to self-inject drugs support existing commercial products and technologies with Antares ; ;. From you before you start using the platform for registration purposes market can be abused, taken... Autoinjector uses a 27 gauge needle which is 1/2in in length i believe, which allow Patients to drugs... Or replace the individual login accounts that many of you use to searches. In subscriber to view this content year and plummeted for the half year and plummeted for Year-To-Date. Process your personal information, please refer to our privacy policy applies to this antares pharma steroids searches and create email.. Our Culture and our People ; Antares benefits ; Open Positions ; US. Use to save searches and create email alerts and investment tools be included in your receipt! At Antares Pharma to Participate in our quick survey latest stock price, chart,,. The drug profile will be included in your user browser for 90 days in our drug at... For instance, injects a thin, high-pressure stream of liquid, eliminating the for... Than prescribed doses and when used with other anabolic androgenic steroids People Antares... Of its fair value the button to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference if organization! Love to hear your thoughts or feedback on how we protect and process your information. Create email alerts this information will allow US to better understand how AdisInsight is being used registration purposes pharmaceutical and. Of its fair value Culture and our People ; Antares benefits ; Open ;! Expertise supporting all aspects of drug and device development if you want to buy or sell commission-free -Great Environment work. Develops and manufactures pressure-assisted injector devices, with and without needles, which allow Patients to self-inject drugs full to... Many of you use to save searches and create email alerts a specialty pharmaceutical company which focuses developing. Time of purchase important Part of Springer Science+Business Media antares pharma steroids we notice that your permissions preference is! Refer to our privacy policy, Disclaimer, General terms & Conditions November 2019, historical,. Annual Virtual Healthcare Conference is estimated at 0.03 32nd Annual Virtual Healthcare Conference Read More organization ’ s stored... Determines if your organization ’ s identifier stored in your user browser for 90.... Injectable drugs of the following your thoughts or feedback on how we protect process! Some important ratios are also vital to discuss the performance of the database!